Answers are grounded in this paper and cite their sources.
Objectives: The prevalence of Celiac Disease (CD) is higher in Type 1 Diabetes Mellitus (T1DM) patients.Our aim is to describe the prevalence of positive Anti-Transglutaminase (anti-tTGA) serology in a cohort of T1DM patients and their tendency in order to stablish a CD diagnosis.Materials and Methods: Retrospective, descriptive, multicenter study of patients with onset of T1DM between 2010-2020, recording demographic, disease-specific and other relevant autoimmune data.Patients were classified in two groups according to whether they had CD and TDM1 (T1DM-CD group) or TMD1 alone (non-CD T1DM group).Anti-tTGA were considered positive in ranges >10NV and indeterminate if <10NV.Results: Information from 262 patients was analyzed.The CD prevalence was 6.4%.258 patients were tested for anti-tTGA titers at T1DM onset: 18 positive, eight had titers >10NV and were diagnosed with CD.The other 10 had indeterminate titers, from these 2 had persistent elevated antibodies therefore a biopsy was done, being confirmatory of CD.The 8 remaining patients had a serologic negativization and not diagnosed with CD.A lower presence of other antibodies was found in the T1DM-CD group compared to the non-CD T1DM group (p<0.05).An increased incidence of CD was observed in patients under 5 years (p=0,551), female gender (p<0.05) and abdominal pain (p<0.05). Conclusion:In T1DM patients it could not be necessary to take a biopsy if the anti-tTGA titers are positive since there is no evidence of a generalized autoimmune status during T1DM onset.If the titers remain indeterminate a biopsy should be done in order to make the CD diagnosis.
No takes yet. Share an insight, caveat, or question.
Rodríguez-Barber et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: